THE PATH FORWARD FROM COVID-19: TREATMENT TO VACCINATION
FEATURED SPEAKERS:
Marion Pepper, Ph.D. - Immunology, University of Washington Medical School
David B. Weiner, Ph.D. - Vaccine & Immunotherapy Center, The Wistar Institute

The Path Forward From Covid-19: Treatment to Vaccination

As states and local governments contemplate a return to communal life, many of us have lingering questions about Covid-19 testing, treatment and vaccination. Recently Glenmede’s CEO, Gordon Fowler, spoke with two specialists in the fields of immunology and immunotherapy.

Featuring guest speakers, Marion Pepper, Ph.D., Associate Professor in the Department of Immunology at the University of Washington School of Medicine and David B. Weiner, Ph.D., Director of the Vaccine and Immunotherapy Center, the W.W. Smith Charitable Trust Professor in Cancer Research and Executive Vice President of The Wistar Institute.

video icon
video icon
video icon


About The Speakers

article-thumbnail

Marion Pepper, Ph.D.

Dr. Pepper is an Associate Professor in the Department of Immunology at the University of Washington School of Medicine. Her research focuses on how protection from disease, known as immunity, develops. Specifically, her lab strives to understand how specialized immune cells, called T cells and B cells, respond to various types of infection or allergic inflammation in an effort to make better vaccines and therapeutics.

Dr. Pepper’s work has been cited over 4,000 times and she is on the editorial board of several top tier journals, including Cell Reports and Immunity. She has served as a scientific consultant for multiple for profit companies focused on immunotherapeutics and is a member of the scientific advisory board of Neoleukin Therapeutics.

She has presented her work at over 70 national and international universities and conferences. In 2017, she was named a recipient of the prestigious Buroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award.

article-thumbnail

David B. Weiner, Ph.D.

Dr. Weiner is the Director of the Vaccine and Immunotherapy Center, the W.W. Smith Charitable Trust Professor in Cancer Research and Executive Vice President of The Wistar Institute.

Dr. Weiner directs a translational molecular immunology research team focused on creating novel approaches for disease prevention and treatment using synthetic nucleic acid technology. With help from collaborators, his group is one of the pioneering research teams in the field of DNA vaccines and immunotherapies and has developed the first clinical studies of DNA vaccines.

He has received several awards and honors, including inclusion as one of the top 40 most influential vaccine scientists in the world, the W.W. Smith Charitable Trust Professorship in Cancer Research, and the Vaccine Industry Excellence Award for Best Academic Research Team.